| Literature DB >> 31163387 |
Katherine A Weissler1, Pamela A Frischmeyer-Guerrerio2.
Abstract
New evidence in humans and mice supports a role for transforming growth factor-β (TGF-β) in the initiation and effector phases of allergic disease, as well as in consequent tissue dysfunction. This pleiotropic cytokine can affect T cell activation and differentiation and B cell immunoglobulin class switching following initial encounter with an allergen. TGF-β can also act on mast cells during an acute allergic episode to modulate the strength of the response, in addition to driving tissue remodeling following damage caused by an allergic attack. Accordingly, genetic disorders leading to altered TGF-β signaling can result in increased rates of allergic disease. Published by Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31163387 PMCID: PMC6800617 DOI: 10.1016/j.coi.2019.05.002
Source DB: PubMed Journal: Curr Opin Immunol ISSN: 0952-7915 Impact factor: 7.486